MEI Pharma Inc
NASDAQ:MEIP
Income Statement
Earnings Waterfall
MEI Pharma Inc
Revenue
|
72.7m
USD
|
Operating Expenses
|
-56.8m
USD
|
Operating Income
|
15.9m
USD
|
Other Expenses
|
4m
USD
|
Net Income
|
19.8m
USD
|
Income Statement
MEI Pharma Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
18
+1 564%
|
23
+25%
|
23
+2%
|
22
-3%
|
6
-75%
|
2
-73%
|
2
+7%
|
2
+13%
|
4
+92%
|
4
+23%
|
5
+13%
|
6
+14%
|
5
-19%
|
5
0%
|
28
+511%
|
33
+20%
|
45
+35%
|
52
+15%
|
35
-33%
|
36
+3%
|
35
-2%
|
37
+4%
|
41
+11%
|
42
+2%
|
63
+50%
|
59
-6%
|
49
-17%
|
105
+116%
|
73
-31%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(3)
|
(4)
|
(5)
|
(5)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
15
N/A
|
19
+22%
|
18
-3%
|
18
-2%
|
2
-88%
|
(2)
N/A
|
(2)
-1%
|
(2)
-10%
|
(1)
+73%
|
0
N/A
|
1
+829%
|
2
+151%
|
1
-41%
|
1
+30%
|
25
+1 907%
|
31
+23%
|
42
+38%
|
50
+17%
|
33
-33%
|
35
+5%
|
35
-1%
|
37
+6%
|
41
+11%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(17)
|
(22)
|
(27)
|
(31)
|
(34)
|
(36)
|
(33)
|
(28)
|
(24)
|
(21)
|
(21)
|
(21)
|
(19)
|
(18)
|
(16)
|
(20)
|
(22)
|
(24)
|
(27)
|
(28)
|
(35)
|
(42)
|
(47)
|
(50)
|
(50)
|
(50)
|
(51)
|
(57)
|
(72)
|
(83)
|
(94)
|
(103)
|
(104)
|
(112)
|
(116)
|
(115)
|
(110)
|
(101)
|
(86)
|
(69)
|
(57)
|
|
Selling, General & Administrative |
(7)
|
(7)
|
(8)
|
(9)
|
(9)
|
(9)
|
(9)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(9)
|
(9)
|
(8)
|
(9)
|
(9)
|
(10)
|
(11)
|
(12)
|
(13)
|
(15)
|
(15)
|
(16)
|
(16)
|
(17)
|
(19)
|
(20)
|
(22)
|
(24)
|
(26)
|
(29)
|
(31)
|
(31)
|
(30)
|
(31)
|
(29)
|
(33)
|
(32)
|
(32)
|
|
Research & Development |
(11)
|
(15)
|
(19)
|
(23)
|
(25)
|
(26)
|
(24)
|
(20)
|
(17)
|
(13)
|
(13)
|
(12)
|
(11)
|
(9)
|
(7)
|
(12)
|
(13)
|
(15)
|
(17)
|
(17)
|
(23)
|
(29)
|
(32)
|
(35)
|
(34)
|
(34)
|
(34)
|
(38)
|
(52)
|
(61)
|
(69)
|
(76)
|
(76)
|
(80)
|
(86)
|
(85)
|
(79)
|
(72)
|
(52)
|
(36)
|
(25)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(17)
N/A
|
(22)
-27%
|
(27)
-24%
|
(31)
-15%
|
(34)
-9%
|
(36)
-5%
|
(33)
+8%
|
(28)
+13%
|
(24)
+14%
|
(21)
+15%
|
(21)
-1%
|
(21)
+2%
|
(4)
+82%
|
1
N/A
|
2
+136%
|
(2)
N/A
|
(20)
-825%
|
(26)
-27%
|
(29)
-12%
|
(30)
-4%
|
(35)
-19%
|
(42)
-19%
|
(46)
-10%
|
(49)
-6%
|
(49)
-1%
|
(49)
+0%
|
(26)
+47%
|
(26)
-1%
|
(30)
-14%
|
(33)
-13%
|
(60)
-81%
|
(68)
-12%
|
(70)
-3%
|
(75)
-7%
|
(75)
-1%
|
(74)
+2%
|
(47)
+36%
|
(42)
+11%
|
(37)
+12%
|
37
N/A
|
16
-57%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(1)
|
(1)
|
(1)
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
3
|
4
|
4
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
(15)
|
9
|
4
|
28
|
42
|
10
|
23
|
(23)
|
(19)
|
(3)
|
(20)
|
19
|
8
|
6
|
28
|
21
|
19
|
14
|
2
|
2
|
0
|
(0)
|
|
Pre-Tax Income |
(17)
N/A
|
(22)
-27%
|
(27)
-24%
|
(31)
-15%
|
(34)
-9%
|
(36)
-5%
|
(33)
+8%
|
(28)
+13%
|
(24)
+14%
|
(21)
+15%
|
(21)
-1%
|
(21)
+2%
|
(4)
+83%
|
1
N/A
|
3
+114%
|
(2)
N/A
|
(20)
-977%
|
(25)
-27%
|
(40)
-59%
|
(46)
-14%
|
(28)
+40%
|
(39)
-41%
|
(17)
+57%
|
(5)
+69%
|
(38)
-612%
|
(24)
+35%
|
(47)
-93%
|
(43)
+8%
|
(31)
+28%
|
(53)
-68%
|
(41)
+21%
|
(60)
-44%
|
(64)
-7%
|
(47)
+27%
|
(54)
-16%
|
(54)
+2%
|
(31)
+42%
|
(38)
-22%
|
(32)
+16%
|
41
N/A
|
20
-52%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(17)
|
(22)
|
(27)
|
(31)
|
(34)
|
(36)
|
(33)
|
(28)
|
(24)
|
(21)
|
(21)
|
(21)
|
(4)
|
1
|
3
|
(2)
|
(20)
|
(25)
|
(40)
|
(46)
|
(28)
|
(39)
|
(17)
|
(5)
|
(38)
|
(24)
|
(47)
|
(43)
|
(31)
|
(53)
|
(41)
|
(60)
|
(64)
|
(47)
|
(54)
|
(54)
|
(31)
|
(38)
|
(32)
|
41
|
20
|
|
Net Income (Common) |
(17)
N/A
|
(22)
-27%
|
(27)
-24%
|
(31)
-15%
|
(34)
-9%
|
(36)
-5%
|
(33)
+8%
|
(28)
+13%
|
(24)
+14%
|
(21)
+15%
|
(21)
-1%
|
(21)
+2%
|
(4)
+83%
|
1
N/A
|
3
+114%
|
(2)
N/A
|
(20)
-977%
|
(25)
-27%
|
(40)
-59%
|
(46)
-14%
|
(28)
+40%
|
(39)
-41%
|
(17)
+57%
|
(5)
+69%
|
(38)
-612%
|
(24)
+35%
|
(47)
-93%
|
(43)
+8%
|
(31)
+28%
|
(53)
-68%
|
(41)
+21%
|
(60)
-44%
|
(64)
-7%
|
(47)
+27%
|
(54)
-16%
|
(54)
+2%
|
(31)
+42%
|
(38)
-22%
|
(32)
+16%
|
41
N/A
|
20
-52%
|
|
EPS (Diluted) |
-17.19
N/A
|
-20.21
-18%
|
-27.15
-34%
|
-28.92
-7%
|
-28.83
+0%
|
-21.29
+26%
|
-23.18
-9%
|
-16.46
+29%
|
-14.13
+14%
|
-12.07
+15%
|
-12.13
0%
|
-11.45
+6%
|
-1.89
+83%
|
0.67
N/A
|
1.45
+116%
|
-0.99
N/A
|
-10.59
-970%
|
-13.45
-27%
|
-19.34
-44%
|
-12.94
+33%
|
-7.78
+40%
|
-10.98
-41%
|
-4.73
+57%
|
-1.45
+69%
|
-9.54
-558%
|
-4.62
+52%
|
-10.36
-124%
|
-7.56
+27%
|
-5.55
+27%
|
-9.33
-68%
|
-7.34
+21%
|
-10.57
-44%
|
-10.04
+5%
|
-7.03
+30%
|
-8.75
-24%
|
-8.04
+8%
|
-4.68
+42%
|
-5.69
-22%
|
-4.78
+16%
|
6.17
N/A
|
2.97
-52%
|